GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Novelix Pharmaceuticals Ltd (BOM:536565) » Definitions » Marketable Securities

Novelix Pharmaceuticals (BOM:536565) Marketable Securities : ₹0.0 Mil (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Novelix Pharmaceuticals Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Novelix Pharmaceuticals's Marketable Securities for the quarter that ended in Dec. 2024 was ₹0.0 Mil.

Novelix Pharmaceuticals's annual Marketable Securities increased from Mar. 2022 (₹0.0 Mil) to Mar. 2023 (₹25.0 Mil) but then stayed the same from Mar. 2023 (₹25.0 Mil) to Mar. 2024 (₹25.0 Mil).

Novelix Pharmaceuticals Marketable Securities Historical Data

The historical data trend for Novelix Pharmaceuticals's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novelix Pharmaceuticals Marketable Securities Chart

Novelix Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 25.00 25.00

Novelix Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 25.00 - 2.25 -

Novelix Pharmaceuticals Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Novelix Pharmaceuticals  (BOM:536565) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Novelix Pharmaceuticals Marketable Securities Related Terms

Thank you for viewing the detailed overview of Novelix Pharmaceuticals's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Novelix Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Novelix Pharmaceuticals Ltd (BOM:536565) » Definitions » Marketable Securities
Comparable Companies
BOM:530697 BOM:543500 BOM:523896 BOM:531240 BOM:544143 MCK COR CAH ASX:SIG SHSE:601607 HSIC HKSE:01099 SHSE:600332 XSWX:GALE MIL:AMP NZSE:EBO TSE:7459 SHSE:600998 SHSE:600511 PDCO
Traded in Other Exchanges
N/A
Address
Chirag Ali Lane, 5-8-354/1106, office No. 1106, Ratna Block, Raghav Ratna towers, Abids, Hyderabad, TG, IND, 500001
Website
https://www.trimurthidrugs.com
Novelix Pharmaceuticals Ltd formerly Trimurthi Ltd is an India based pharmaceutical supplier. It operates as a holding company, which engages in the distribution, retail, and marketing of pharmaceutical products. It operates through the following business segments: Pharma Business, Financial Activity, Investment Activity, Foods, and Trading in Shares. Its products include medicine for contraception, obstetrics and gynecology, digestive system, and other areas.

Novelix Pharmaceuticals Headlines

No Headlines